Anirban Basu

Summary

Publications

  1. ncbi Tying comparative effectiveness information to decision-making and the future of comparative effectiveness research designs: the case for antipsychotic drugs
    Anirban Basu
    Department of Health Services, PORPP, University of Washington, 1959 NE Pacific St, Box 357660, Seattle, WA 98195 7660, USA
    J Comp Eff Res 1:171-80. 2012
  2. doi Private manufacturers' thresholds to invest in comparative effectiveness trials
    Anirban Basu
    Department of Health Services and Pharmaceutical Outcomes Research and Policy Program PORPP, University of Washington, Seattle, WA 98195 7660, USA
    Pharmacoeconomics 30:859-68. 2012
  3. doi Regression estimators for generic health-related quality of life and quality-adjusted life years
    Anirban Basu
    Department of Health Services, University of Washington, Seattle, WA, USA
    Med Decis Making 32:56-69. 2012
  4. pmc Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care
    Anirban Basu
    Department of Health Services, University of Washington, Seattle, 1959 NE Pacific St, Box 357660, Seattle, WA 98195 7660, USA
    J Health Econ 30:549-59. 2011
  5. pmc The impact of comparative effectiveness research on health and health care spending
    Anirban Basu
    University of Washington, USA
    J Health Econ 30:695-706. 2011
  6. pmc Comparative cost analysis of housing and case management program for chronically ill homeless adults compared to usual care
    Anirban Basu
    Department of Health Services, University of Washington, Seattle, WA, USA
    Health Serv Res 47:523-43. 2012

Detail Information

Publications6

  1. ncbi Tying comparative effectiveness information to decision-making and the future of comparative effectiveness research designs: the case for antipsychotic drugs
    Anirban Basu
    Department of Health Services, PORPP, University of Washington, 1959 NE Pacific St, Box 357660, Seattle, WA 98195 7660, USA
    J Comp Eff Res 1:171-80. 2012
    ..The value of genomic information in enabling better trial design is also discussed. ..
  2. doi Private manufacturers' thresholds to invest in comparative effectiveness trials
    Anirban Basu
    Department of Health Services and Pharmaceutical Outcomes Research and Policy Program PORPP, University of Washington, Seattle, WA 98195 7660, USA
    Pharmacoeconomics 30:859-68. 2012
    ..However, whether the potential effects we highlight of public funding of CER and of Bayesian approaches to trial design actually produce changes in private investment in CER remains an empirical question...
  3. doi Regression estimators for generic health-related quality of life and quality-adjusted life years
    Anirban Basu
    Department of Health Services, University of Washington, Seattle, WA, USA
    Med Decis Making 32:56-69. 2012
    ..To develop regression models for outcomes with truncated supports, such as health-related quality of life (HRQoL) data, and account for features typical of such data such as a skewed distribution, spikes at 1 or 0, and heteroskedasticity...
  4. pmc Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care
    Anirban Basu
    Department of Health Services, University of Washington, Seattle, 1959 NE Pacific St, Box 357660, Seattle, WA 98195 7660, USA
    J Health Econ 30:549-59. 2011
    ..Using an example of the comparative effect of substance abuse treatments on crime, I use novel econometric methods to salvage individualized information from an existing dataset...
  5. pmc The impact of comparative effectiveness research on health and health care spending
    Anirban Basu
    University of Washington, USA
    J Health Econ 30:695-706. 2011
    ....
  6. pmc Comparative cost analysis of housing and case management program for chronically ill homeless adults compared to usual care
    Anirban Basu
    Department of Health Services, University of Washington, Seattle, WA, USA
    Health Serv Res 47:523-43. 2012
    ..To assess the costs of a housing and case management program in a novel sample-homeless adults with chronic medical illnesses...